Filed with the SEC on · accession 0001193125-26-428916
RCUS filed a 424B5 (prospectus (offering)) with the SEC on Oct 22, 2026. Arcus Biosciences, Inc. is offering 14,285,715 shares of common stock at $17.50 per share, raising approximately $250 million in gross proceeds. The stock moved +1.4% by the first close after the filing.
Arcus Biosciences, Inc. is offering 14,285,715 shares of common stock at $17.50 per share, raising approximately $250 million in gross proceeds. The offering includes a 30-day option for underwriters to purchase up to an additional 2,142,857 shares.
Close before
$19.10
Oct 21, 2026
First close after
+1.36%
$19.36
5 trading days
-3.72%
$18.39
Since filing
-4.29%
$18.28
✦ Ask GOAX AI about this filing — what it means for RCUS, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for RCUS?
Click hereRCUS filed a 424B5 (Secondary offering). Arcus Biosciences, Inc. is offering 14,285,715 shares of common stock at $17.50 per share, raising approximately $250 million in gross proceeds. The offering includes a 30-day option for underwriters to purchase up to an additional 2,142,857 shares.
New shares dilute existing holders and are often sold at a discount to the market price.
The final terms of an offering of shares or bonds. Look at price, number of shares and the discount to the market price. Large offerings dilute existing shareholders.
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 424B5 (prospectus (offering)): The final terms of an offering of shares or bonds.
RCUS closed at $19.10 before the filing and $19.36 on Oct 22, 2026 (+1.36%). Five trading days later: $18.39 (-3.72%).
Get alerts when RCUS files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days